top of page

Proud Moment for TADA Group AB: Patent Approval in Egypt

ReLink is now approved in Egypt

A new milestone indeed! We are proud to share that we have received a patent approval on ReLink in Egypt.

ReLink, a solution to a global healthcare problem

ReLink is a breakaway connector, designed and engineered to increase safety, accuracy, and efficiency of IV therapy in healthcare settings.

ReLink is specially engineered to enhance infusion stability by keeping connections of IV catheters to the patients with a controlled break away and predictable results, providing increased safety for patients and nurses across the globe.

We look forward to receiving a patent on our technology in more countries and contribute to the field of health care with our innovative solutions.

bottom of page